AU2810497A - Methods for inducing bone formation - Google Patents

Methods for inducing bone formation

Info

Publication number
AU2810497A
AU2810497A AU28104/97A AU2810497A AU2810497A AU 2810497 A AU2810497 A AU 2810497A AU 28104/97 A AU28104/97 A AU 28104/97A AU 2810497 A AU2810497 A AU 2810497A AU 2810497 A AU2810497 A AU 2810497A
Authority
AU
Australia
Prior art keywords
methods
bone formation
inducing bone
inducing
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28104/97A
Inventor
Diane M. Durnam
Joseph L Kuijper
Chung C. Liu
David S Weigle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Zymogenetics Inc
Original Assignee
University of Washington
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Zymogenetics Inc filed Critical University of Washington
Publication of AU2810497A publication Critical patent/AU2810497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/355—Leptin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/07—Coculture with; Conditioned medium produced by endocrine cells
    • C12N2502/076—Coculture with; Conditioned medium produced by endocrine cells pituitary cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU28104/97A 1996-04-19 1997-04-18 Methods for inducing bone formation Abandoned AU2810497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1564796P 1996-04-19 1996-04-19
US60015647 1996-04-19
PCT/US1997/006892 WO1997039767A1 (en) 1996-04-19 1997-04-18 Methods for inducing bone formation

Publications (1)

Publication Number Publication Date
AU2810497A true AU2810497A (en) 1997-11-12

Family

ID=21772637

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28104/97A Abandoned AU2810497A (en) 1996-04-19 1997-04-18 Methods for inducing bone formation

Country Status (5)

Country Link
EP (1) EP0917469A1 (en)
JP (1) JP2000509377A (en)
AU (1) AU2810497A (en)
CA (1) CA2251808A1 (en)
WO (1) WO1997039767A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950417A3 (en) 1998-02-23 2000-02-23 Pfizer Products Inc. Treatment of skeletal disorders
AU3147699A (en) * 1998-03-27 1999-10-18 Andre Rosenthal Nucleic acid molecules which code proteins influencing bone development
WO1999053939A1 (en) * 1998-04-20 1999-10-28 Mayo Foundation For Medical Education And Research Treatment of osteoporosis with leptin
JP2003528804A (en) * 1999-06-11 2003-09-30 ベイラー・カレッジ・オブ・メディスン Methods and compositions for controlling bone formation through modulation of leptin activity
AU767068B2 (en) * 1999-06-11 2003-10-30 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of leptin activity
AU781936C (en) * 1999-08-03 2006-02-16 University Of Melbourne, The A method of treatment and agents useful for same
WO2001068135A2 (en) * 2000-03-14 2001-09-20 The University Of Western Ontario Compositions and methods for affecting osteogenesis
EP3903772A1 (en) * 2014-05-30 2021-11-03 The Research Foundation for The State University of New York Compositions and methods to promote bone formation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
ES2217327T3 (en) * 1995-11-22 2004-11-01 Amgen Inc., PROTEIN OB TO INCREASE THE MAGRO FABRIC MASS.

Also Published As

Publication number Publication date
EP0917469A1 (en) 1999-05-26
CA2251808A1 (en) 1997-10-30
JP2000509377A (en) 2000-07-25
WO1997039767A1 (en) 1997-10-30

Similar Documents

Publication Publication Date Title
AU2917497A (en) Surgical apparatus
AU4991997A (en) Apparatus for fusing adjacent bone structures
AU1221197A (en) Spine implant
AU5855796A (en) Methods for inhibiting bone loss
AU1224895A (en) Bone anchor
AU5407598A (en) Bone implant
AU3127597A (en) Reflected-image videoendoscopic surgical trainer
AU3989297A (en) Hyper-text document preparing apparatus
AU3497297A (en) Roller-ski apparatus
AU5486596A (en) Surgical method
AUPO359796A0 (en) Cutter apparatus
AU4347097A (en) Apparatus for tissue preparation
AU5317398A (en) Method for preparing cyclopropylamines
AU5751298A (en) Method for producing arylcyanates
AU6043096A (en) Methods for minimizing bone loss
AU1733997A (en) Blower-vacuum apparatus
AU5743396A (en) Methods for inhibiting bone loss
AU2810497A (en) Methods for inducing bone formation
AU2183997A (en) New method
AU3704297A (en) Method
AU2542997A (en) Anesthetic method
AU5743696A (en) Methods for inhibiting bone loss
AU7512396A (en) Plug for the cranial bone
AU5981696A (en) Methods for minimizing bone loss
AU2987097A (en) De-wiring apparatus

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted